TL;DR
Global Cosmetics News’ Week 43 review reported mixed commercial results, including sales growth at P&G and Puig alongside a decline in China’s online beauty sales. Regulatory proposals, international investment, leadership changes and disruption to retail and manufacturing also featured. The review does not provide detailed figures or independent verification for every item.
Global Cosmetics News’ Week 43 review described a cosmetics and personal care industry facing contrasting sales conditions, regulatory changes and operational disruption. According to the review, P&G reported 4% fiscal first-quarter sales growth and Puig recorded record third-quarter sales, while online beauty sales in China fell 6% in September. The roundup also covered new compliance measures, international expansion and retail and manufacturing interruptions.
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
According to the Global Cosmetics News review, P&G’s sales growth was supported by a stronger Beauty division, while Puig recorded its highest third-quarter sales, with make-up and Asia-Pacific contributing to growth. The review also reported that Dolce & Gabbana Beauty was targeting double-digit growth through international expansion. These positive developments contrasted with a 6% decline in China’s online beauty sales in September, which the roundup associated with weaker demand and increased competition for multinational brands.
The review said companies were also adjusting their operations and investment plans. It reported that Unilever sold its Welly bandage brand to Forward Consumer Partners, and that Solabia refocused on cosmetics and nutraceuticals following Muriel Koch’s appointment as chief executive. Proya Cosmetics opened a European innovation laboratory in France, according to the roundup. The review also said THG raised its 2026 profit forecast, Walmart was targeting a US$6.5 billion bond sale, and Malaysia’s Big Caring Pharmacy chain outlined plans for a US$600 million initial public offering.
On regulation and disruption, Global Cosmetics News reported that the UK government proposed tighter restrictions on high-risk cosmetic procedures, Indonesia extended halal-certification deadlines for cosmetics and personal care products to 2028, and the US Food and Drug Administration cleared a Phase 2 clinical trial investigating injectable platelet-derived growth factor for under-eye hollows. The roundup also said Sephora closed stores in France amid civil unrest and that a Russian attack damaged Ukrainian personal care manufacturer 2K, forcing a production halt.
Sales Divergence Meets Compliance Changes
The Global Cosmetics News roundup points to a market in which results vary by company and region: growth at some large beauty groups did not prevent a decline in China’s online beauty market. For brands and retailers, that divergence may affect where they focus investment, marketing and product launches, although the roundup does not quantify the impact on individual companies.
The regulatory developments reported in the review also have potential implications for businesses operating in affected markets. The UK proposal could change who is permitted to perform certain high-risk cosmetic procedures if adopted, while Indonesia’s extended deadline gives companies more time to meet halal-certification requirements. Separately, the roundup’s reports of retail closures and a production halt in Ukraine illustrate how civil unrest and conflict can interrupt access to products and normal operations.
Products Worth Considering
Therabody SmartGoggles 2nd Gen Heated Eye and Temple Massager
Therabody SleepMask Blackout Eye Mask with Vibration
Fitbit Charge 6 Fitness Tracker Bundle – Black/Obsidian
As an affiliate, we earn on qualifying purchases.
A Week of Corporate and Market Shifts
The Week 43 roundup brings together developments across financial performance, portfolio decisions, governance, research and regulation. Global Cosmetics News reported leadership changes at companies including dsm-firmenich, Chanel and Dermalogica, as well as L’Oréal appointments to boards of Chinese manufacturing subsidiaries. The roundup also covered brand activity, including Maybelline New York naming Hannah El Zahed its first ambassador in Egypt and a limited-edition lip stain collaboration between Virgin and Wonderskin.
The review also covered items beyond conventional beauty trading, including Getty Images’ bankruptcy protection filing amid AI competition and debt restructuring. Its collection of developments shows the range of business and external factors affecting the sector during the week, but it is a weekly summary rather than a full account of each company’s results or each government measure.
Details Behind the Weekly Headlines
The supplied Global Cosmetics News roundup is brief and does not include links to underlying company filings, government documents or detailed market data for every item. It does not specify the exact financial figures behind Puig’s record sales, the basis for the China sales comparison, or the expected timing and final terms of the proposed UK restrictions. The review describes Walmart’s bond sale and Big Caring Pharmacy’s IPO as plans, not as completed transactions.
The roundup gives no further detail on the FDA-cleared trial, including its design, recruitment or expected results. It also does not state when 2K’s production might resume, how long the reported store closures lasted, or the full scale of their commercial effects. These points remain unconfirmed in the supplied source material.
Company Plans and Rules Ahead
The Global Cosmetics News review says companies have stated plans whose progress remains to be reported, including Dolce & Gabbana Beauty’s international growth ambitions, Walmart’s proposed bond sale and Big Caring Pharmacy’s planned IPO. Proya’s new French laboratory is an operational development; the review does not specify when products or research from the facility may reach markets.
Regulatory follow-up will depend on decisions by the relevant authorities. The review describes the UK measure as a proposal, while manufacturers selling cosmetics and personal care products in Indonesia have until 2028 under the extended halal-certification timetable it reports. Further information on the clinical trial and the recovery of disrupted retail and manufacturing operations may clarify the effects of this week’s developments.
Key Questions
What was the main takeaway from the Week 43 review?
Global Cosmetics News reported contrasting sales trends, regulatory developments and operational disruption, with growth at P&G and Puig alongside weaker online beauty sales in China.
What did the review report about China’s beauty market?
The Global Cosmetics News roundup said online beauty sales in China declined 6% in September, amid weaker demand and increased competition. It does not provide the comparison baseline or further market data.
What regulatory changes were mentioned?
The review described a UK government proposal for tighter restrictions on high-risk cosmetic procedures, an Indonesian extension of halal-certification deadlines to 2028, and FDA clearance for a Phase 2 trial of an injectable treatment for under-eye hollows.
Were the reported financing plans completed?
The roundup described Walmart as targeting a US$6.5 billion bond sale and Big Caring Pharmacy as outlining a planned US$600 million IPO. It does not say either transaction had been completed.
What operational disruptions did the review identify?
Global Cosmetics News reported store closures by Sephora in France amid civil unrest and damage to Ukrainian personal care manufacturer 2K after a Russian attack, which forced the company to halt production. The source does not say when normal operations would resume.
Source: rss
